COMP <GO>
ESTA vs ABBV // RETURN ON INVESTED CAPITAL (ROIC)
Establishment Labs Holdings Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ESTA 1
— ABBV 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ABBV
LAST: $68.41 (-0.81%) • MKT CAP: $2.04B
roic
-15.80%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
roic
29.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESTA VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESTA | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.30% | 70.20% | -0.90 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -15.80% | 29.00% | -44.80 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.79% | 3.47% | -6.26 | ABBV | /fcf-yield <GO> |
| Operating Margin | -18.50% | 24.60% | -43.10 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -24.20% | 6.90% | -31.10 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 27.10% | 8.60% | +18.50 | ESTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 5.33 | -2.81 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 65.1 | -20.22 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.04B | $513.86B | -$511.82B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESTA REV | ABBV REV | ESTA GROSS % | ABBV GROSS % | ESTA FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $211.1M | $61.16B | 69.3% | 70.2% | -$56.9M | $17.82B |
| FY 2024 | $166.0M | $56.33B | 66.0% | 70.0% | -$64.6M | $17.83B |
| FY 2023 | $165.2M | $54.32B | — | — | -$88.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESTA // BETA —
ABBV // BETA 1.15